BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs4950928
,
DRD2
,
Coagulation
,
Pseudomonas infection
,
Neuron
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peptide
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Cell-penetrating peptides for sustainable agriculture.
Molecular farming for sustainable production of clinical-grade antimicrobial peptides.
Harnessing antimicrobial peptides in endodontics.
Mimicking Nonribosomal Peptides from the Marine Actinomycete Streptomyces sp. H-KF8 Leads to Antimic…
Embracing the era of antimicrobial peptides with marine organisms.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
High Energy High Protein Peptide Feed Study
Melanoma Vaccine With Peptides and Leuprolide
B-type Natriuretic Peptide and Glucose Metabolism
Metabolic Effects of Natriuretic Peptide Hormones
Liver-enriched Antimicrobial Peptide 2
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ